vs
Esperion Therapeutics, Inc.（ESPR）与SPORTSMAN'S WAREHOUSE HOLDINGS, INC.（SPWH）财务数据对比。点击上方公司名可切换其他公司
SPORTSMAN'S WAREHOUSE HOLDINGS, INC.的季度营收约是Esperion Therapeutics, Inc.的2.0倍（$331.3M vs $168.4M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 2.2%），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs -5.4%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
运动员仓库控股（Sportsman's Warehouse）是美国户外体育用品零售商，门店遍布全美29个州，主要面向狩猎、射击、露营、垂钓等各类户外休闲运动爱好者，销售户外服饰、鞋履及专业运动装备。
ESPR vs SPWH — 直观对比
营收规模更大
SPWH
是对方的2.0倍
$168.4M
营收增速更快
ESPR
高出141.5%
2.2%
两年增速更快
ESPR
近两年复合增速
-5.4%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $331.3M |
| 净利润 | — | $8.0K |
| 毛利率 | — | 32.8% |
| 营业利润率 | 50.6% | 1.3% |
| 净利率 | — | 0.0% |
| 营收同比 | 143.7% | 2.2% |
| 净利润同比 | — | -97.8% |
| 每股收益（稀释后） | $0.32 | $0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRSPWH
| Q4 25 | $168.4M | $331.3M | ||
| Q3 25 | $87.3M | $293.9M | ||
| Q2 25 | $82.4M | $249.1M | ||
| Q1 25 | $65.0M | $340.4M | ||
| Q4 24 | $69.1M | $324.3M | ||
| Q3 24 | $51.6M | $288.7M | ||
| Q2 24 | $73.8M | $244.2M | ||
| Q1 24 | $137.7M | $370.4M |
净利润ESPRSPWH
| Q4 25 | — | $8.0K | ||
| Q3 25 | $-31.3M | $-7.1M | ||
| Q2 25 | $-12.7M | $-21.3M | ||
| Q1 25 | $-40.5M | $-8.7M | ||
| Q4 24 | — | $-364.0K | ||
| Q3 24 | $-29.5M | $-5.9M | ||
| Q2 24 | $-61.9M | $-18.1M | ||
| Q1 24 | $61.0M | $-8.7M |
毛利率ESPRSPWH
| Q4 25 | — | 32.8% | ||
| Q3 25 | — | 32.0% | ||
| Q2 25 | — | 30.4% | ||
| Q1 25 | — | 30.4% | ||
| Q4 24 | — | 31.8% | ||
| Q3 24 | — | 31.2% | ||
| Q2 24 | — | 30.2% | ||
| Q1 24 | — | 26.8% |
营业利润率ESPRSPWH
| Q4 25 | 50.6% | 1.3% | ||
| Q3 25 | -11.4% | -1.1% | ||
| Q2 25 | 8.6% | -7.9% | ||
| Q1 25 | -34.0% | 1.1% | ||
| Q4 24 | -6.4% | 1.0% | ||
| Q3 24 | -31.0% | -1.5% | ||
| Q2 24 | 3.5% | -8.4% | ||
| Q1 24 | 52.5% | -2.1% |
净利率ESPRSPWH
| Q4 25 | — | 0.0% | ||
| Q3 25 | -35.9% | -2.4% | ||
| Q2 25 | -15.4% | -8.5% | ||
| Q1 25 | -62.2% | -2.6% | ||
| Q4 24 | — | -0.1% | ||
| Q3 24 | -57.2% | -2.0% | ||
| Q2 24 | -83.9% | -7.4% | ||
| Q1 24 | 44.3% | -2.4% |
每股收益（稀释后）ESPRSPWH
| Q4 25 | $0.32 | $0.00 | ||
| Q3 25 | $-0.16 | $-0.18 | ||
| Q2 25 | $-0.06 | $-0.56 | ||
| Q1 25 | $-0.21 | $-0.22 | ||
| Q4 24 | $-0.14 | $-0.01 | ||
| Q3 24 | $-0.15 | $-0.16 | ||
| Q2 24 | $-0.33 | $-0.48 | ||
| Q1 24 | $0.34 | $-0.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $2.2M |
| 总债务越低越好 | — | $44.0M |
| 股东权益账面价值 | $-302.0M | $209.5M |
| 总资产 | $465.9M | $913.9M |
| 负债/权益比越低杠杆越低 | — | 0.21× |
8季度趋势，按日历期对齐
现金及短期投资ESPRSPWH
| Q4 25 | $167.9M | $2.2M | ||
| Q3 25 | $92.4M | $1.8M | ||
| Q2 25 | $86.1M | $3.6M | ||
| Q1 25 | $114.6M | $2.8M | ||
| Q4 24 | $144.8M | $2.7M | ||
| Q3 24 | $144.7M | $2.6M | ||
| Q2 24 | $189.3M | $2.2M | ||
| Q1 24 | $226.6M | $3.1M |
总债务ESPRSPWH
| Q4 25 | — | $44.0M | ||
| Q3 25 | — | $43.9M | ||
| Q2 25 | — | $24.1M | ||
| Q1 25 | — | $24.1M | ||
| Q4 24 | — | $24.0M | ||
| Q3 24 | — | $24.0M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ESPRSPWH
| Q4 25 | $-302.0M | $209.5M | ||
| Q3 25 | $-451.4M | $208.9M | ||
| Q2 25 | $-433.5M | $215.1M | ||
| Q1 25 | $-426.2M | $235.7M | ||
| Q4 24 | $-388.7M | $243.6M | ||
| Q3 24 | $-370.2M | $243.0M | ||
| Q2 24 | $-344.2M | $247.5M | ||
| Q1 24 | $-294.3M | $264.6M |
总资产ESPRSPWH
| Q4 25 | $465.9M | $913.9M | ||
| Q3 25 | $364.0M | $948.9M | ||
| Q2 25 | $347.1M | $929.7M | ||
| Q1 25 | $324.0M | $852.1M | ||
| Q4 24 | $343.8M | $967.7M | ||
| Q3 24 | $314.1M | $901.9M | ||
| Q2 24 | $352.3M | $930.4M | ||
| Q1 24 | $373.1M | $886.2M |
负债/权益比ESPRSPWH
| Q4 25 | — | 0.21× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.10× | ||
| Q4 24 | — | 0.10× | ||
| Q3 24 | — | 0.10× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | $16.3M |
| 自由现金流经营现金流 - 资本支出 | — | $8.7M |
| 自由现金流率自由现金流/营收 | — | 2.6% |
| 资本支出强度资本支出/营收 | 0.0% | 2.3% |
| 现金转化率经营现金流/净利润 | — | 2038.00× |
| 过去12个月自由现金流最近4个季度 | — | $-39.7M |
8季度趋势，按日历期对齐
经营现金流ESPRSPWH
| Q4 25 | $45.2M | $16.3M | ||
| Q3 25 | $-4.3M | $-26.6M | ||
| Q2 25 | $-31.4M | $-60.2M | ||
| Q1 25 | $-22.6M | $52.8M | ||
| Q4 24 | $-35.0M | $-2.5M | ||
| Q3 24 | $-35.3M | $18.5M | ||
| Q2 24 | $-7.2M | $-34.6M | ||
| Q1 24 | $53.8M | $68.9M |
自由现金流ESPRSPWH
| Q4 25 | — | $8.7M | ||
| Q3 25 | — | $-33.9M | ||
| Q2 25 | — | $-64.0M | ||
| Q1 25 | — | $49.6M | ||
| Q4 24 | — | $-6.2M | ||
| Q3 24 | $-35.5M | $14.1M | ||
| Q2 24 | $-7.3M | $-38.0M | ||
| Q1 24 | $53.8M | $60.2M |
自由现金流率ESPRSPWH
| Q4 25 | — | 2.6% | ||
| Q3 25 | — | -11.5% | ||
| Q2 25 | — | -25.7% | ||
| Q1 25 | — | 14.6% | ||
| Q4 24 | — | -1.9% | ||
| Q3 24 | -68.7% | 4.9% | ||
| Q2 24 | -9.9% | -15.5% | ||
| Q1 24 | 39.0% | 16.2% |
资本支出强度ESPRSPWH
| Q4 25 | 0.0% | 2.3% | ||
| Q3 25 | 0.0% | 2.5% | ||
| Q2 25 | 0.0% | 1.5% | ||
| Q1 25 | 0.0% | 1.0% | ||
| Q4 24 | 0.0% | 1.1% | ||
| Q3 24 | 0.3% | 1.5% | ||
| Q2 24 | 0.1% | 1.4% | ||
| Q1 24 | 0.1% | 2.4% |
现金转化率ESPRSPWH
| Q4 25 | — | 2038.00× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
SPWH
暂无分部数据
